Josephine Anne Lucero (Josephine Lucero)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Venues

Annals of hematology

OncoTargets and therapy

Current oncology (Toronto, Ont.)

Current hematologic malignancy reports

This page only lists publications with an associated author ORCID identifier.

Publications

Josephine Anne Lucero, Muhned Alhumaid, Igor Novitzky-Basso, Jose-Mario Capo-Chichi, Tracy Stockley, Vikas Gupta, Aniket Bankar, Steven Chan, Andre C Schuh, Mark Minden, Jonas Mattsson, Rajat Kumar, Hassan Sibai, Anne Tierens, Dennis D H Kim
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Annals of hematology (2024)
Josephine Anne Lucero, Muhned Alhumaid, Igor Novitzky-Basso, Jose-Mario Capo-Chichi, Tracy Stockley, Vikas Gupta, Aniket Bankar, Steven Chan, Andre C Schuh, Mark Minden, Jonas Mattsson, Rajat Kumar, Hassan Sibai, Anne Tierens, Dennis D H Kim
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Annals of hematology 103 (4) (2024)
Josephine Anne Lucero, Muhned Alhumaid, Igor Novitzky-Basso, Jose-Mario Capo-Chichi, Tracy Stockley, Vikas Gupta, Aniket Bankar, Steven Chan, Andre C Schuh, Mark Minden, Jonas Mattsson, Rajat Kumar, Hassan Sibai, Anne Tierens, Dennis D H Kim
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Annals of hematology 103 (4) (2024)
Josephine Anne Lucero, Muhned Alhumaid, Igor Novitzky-Basso, Jose-Mario Capo-Chichi, Tracy Stockley, Vikas Gupta, Aniket Bankar, Steven Chan, Andre C Schuh, Mark Minden, Jonas Mattsson, Rajat Kumar, Hassan Sibai, Anne Tierens, Dennis D H Kim
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Annals of hematology 103 (4) (2024)
Josephine Anne Lucero, Salman Al-Harbi, Karen W L Yee
Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS). Current oncology (Toronto, Ont.) 30 (7) (2023)
Josephine Anne Lucero, Jeffrey H Lipton
A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment. Current hematologic malignancy reports (2023)
Danielle Benedict Leoncio Sacdalan, Josephine Anne Lucero
The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development. OncoTargets and therapy 14 (2021)

Josephine Anne Lucero.css-eqlu8i{font-size:small;padding-left:4px;} (Josephine Lucero)

Publication Activity (10 Years)

Top Topics

Top Venues

Josephine Anne Lucero (Josephine Lucero)